Tempest Therapeutics (TPST) Price to Book (2012 - 2026)

Tempest Therapeutics has disclosed Price to Book across 15 years of filings, most recently posting 5.02 for Q2 2026.

• In Q2 2026, Price to Book fell 262.66% year-over-year to 5.02; the TTM figure through Jun 2026 stood at 5.02 (down 262.66% YoY), while the FY2025 annual figure was 2.12, up 74.18% from the prior year.
• Price to Book came in at 5.02 for Q2 2026 at Tempest Therapeutics, down from 2.12 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 7.19 in Q3 2025 to a low of 5.02 in Q2 2026.
• Average Price to Book over 5 years is 1.78, with a median of 2.53 recorded in 2023.
• The largest YoY upside for Price to Book was 401.75% in 2023 against a maximum downside of 513.73% in 2023.
• Over 5 years, Price to Book stood at 0.67 in 2022, then soared by 279.41% to 2.53 in 2023, then tumbled by 51.95% to 1.22 in 2024, then jumped by 74.18% to 2.12 in 2025, then sank by 336.6% to 5.02 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 5.02 in Q2 2026, 2.12 in Q4 2025, and 7.19 in Q3 2025.